Shoron Mowla

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “MEN1 mutations mediate clinical resistance to menin inhibition”.

MEN1 mutations mediate clinical resistance to menin inhibition

Nature(2023)10.1038/s41586-023-05755-9

N/A

0.829DataRank · unranked

251 citations

Eytan M. Stein, Daniela V. Wenge, Sukrit Singh, Jeonghyeon Kim, Athina Apazidis +24 more

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation

Blood(2022)10.1182/blood.2021014465

N/A

0.542DataRank · unranked

36 citations

Wenbin An, Hua Wang, Timour Baslan, Shoron Mowla, Aishwarya Krishnan +13 more

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms

Cancer Discovery(2024)10.1158/2159-8290.cd-22-0952

N/A

0.515DataRank · unranked

30 citations

Robert L. Bowman, Young C. Park, Kavi O’Connor, Franco Izzo, Robert M. Myers +29 more

In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy

Cancer Cell(2024)10.1016/j.ccell.2024.10.009

N/A

0.484DataRank · unranked

11 citations

Andrew Dunbar, Tanmay Mishra, Wenbin Xiao, Michael R. Waarts, Inés Fernández-Maestre +30 more

Modeling clonal evolution and oncogenic dependency in vivo in the context of hematopoietic transformation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.18.492524

N/A

0.165DataRank · unranked

2 citations

Andrew Dunbar, Tanmay Mishra, Wenbin Xiao, Michael R. Waarts, Inés Fernández-Maestre +20 more

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis

Blood(2023)10.1182/blood.2022015418

N/A

0DataRank · unranked

37 citations

Dongjoo Kim, Min Lü, Mirko Farina, Robert L. Bowman, Julie L. Yang +34 more

Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4898

N/A

0DataRank · unranked

22 citations

Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, Benjamin H. Durham, Richard P. Koche, Barbara Spitzer +15 more

CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2 - and TET2 -mutant Cells

Cancer Discovery(2024)10.1158/2159-8290.cd-23-1092

N/A

0DataRank · unranked

11 citations

Shoron Mowla, Meaghan Boileau, Anthony R. Martinez Benitez, Junya Sango, Maya Bagish +20 more